Vacunas meningocócicas

Echezuría, Luis; Rísquez, Alejandro; Castillo de Febres, Olga.
Arch. venez. pueric. pediatr ; 74(4): 169-172, dic. 2011.
Artículo en Español | LILACS | ID: lil-659194

Documentos relacionados

  1. [<b>A phase</b> Ⅲ <b>clinical trial study on the safety and immunogenicity of ACYW135 group meningococcal conjugate vaccine inoculated in 3 month old infants</b>].
  2. [A new meningococcal conjugate vaccine (Menveo)].
  3. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
  4. [Bexsero, a novel vaccine against meningococcus].
  5. Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study.
  6. Propositive follow-up: Long-term immune responses to the 4CMenB and MenACWY vaccines in people living with HIV.
  7. Meningococcal Vaccine in Mali and Gambia. Reply.
  8. Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
  9. Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study.
  10. Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia.